Jaynier Moya
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Hormonal Regulation and Hypertension
- Diabetes Treatment and Management
Papers in
-
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
-
- Influenza Virus Research Studies 2
- Herpesvirus Infections and Treatments 1
- Co-authors
- Erik De Clercq (1 shared paper)Ana María Sandino (1 shared paper)Manuel Guzmán (1 shared paper)I. S. F. Chan (1 shared paper)Florian P. Schödel (1 shared paper)Katia Schlienger (1 shared paper)JERALD C. SADOFF (1 shared paper)Jeffrey L. Silber (1 shared paper)
- Journals
- Open Forum Infectious Diseases (4 papers)The Lancet (2 papers)Vaccine (1 paper)Antiviral Research (1 paper)JAMA (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Jaynier Moya
11 papers receiving 594 citations
Jaynier Moya's Hit Papers
Peers
Comparison fields: 5 of 74
- Infectious Diseases 184
- Endocrinology, Diabetes and Metabolism 115
- Cardiology and Cardiovascular Medicine 150
- Internal Medicine 22
- Nephrology 30
Countries citing papers authored by Jaynier Moya
This map shows the geographic impact of Jaynier Moya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaynier Moya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaynier Moya more than expected).
Fields of papers citing papers by Jaynier Moya
This network shows the impact of papers produced by Jaynier Moya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaynier Moya. The network helps show where Jaynier Moya may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaynier Moya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19 Hit paper breakdown → | 2022 | 207 |
| 2 | 2019 | 159 | |
| 3 | Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial Hit paper breakdown → | 2023 | 142 |
| 4 | 2006 | 38 | |
| 5 | 2000 | 17 | |
| 6 | 2024 | 15 | |
| 7 | 2023 | 14 | |
| 8 | 2021 | 11 | |
| 9 | 2023 | 5 | |
| 10 | 2024 | 3 | |
| 11 | 2022 | 2 | |
| 12 | 2026 | 0 |
About Jaynier Moya
Jaynier Moya is a scholar working on Infectious Diseases, Epidemiology, Aquatic Science, Animal Science and Zoology and Endocrinology, Diabetes and Metabolism, having authored 12 papers that have together received 613 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (2 papers), Influenza Virus Research Studies (2 papers), Animal Virus Infections Studies (1 paper), Aquaculture disease management and microbiota (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Herpesvirus Infections and Treatments (1 paper) and Antiplatelet Therapy and Cardiovascular Diseases (1 paper). The work is most often cited by research in Infectious Diseases (184 citations), Endocrinology, Diabetes and Metabolism (115 citations), Cardiology and Cardiovascular Medicine (150 citations), Internal Medicine (22 citations) and Nephrology (30 citations). Jaynier Moya has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Erik De Clercq, Ana María Sandino, Manuel Guzmán, I. S. F. Chan, Florian P. Schödel, Katia Schlienger, JERALD C. SADOFF, Jeffrey L. Silber, Charles M. Fogarty and Maria L. Agostini. Their work appears in journals such as Open Forum Infectious Diseases, The Lancet, Vaccine, Antiviral Research and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.